ORIGINAL RESEARCH article
Front. Med.
Sec. Rheumatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1625742
Validation of "Clinical Red Flags" for RA-ILD in an Italian cohort
Provisionally accepted- 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome “Tor Vergata”, Rome, Italy
- 2Division of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy
- 3Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, Rome, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Rheumatoid arthritis (RA) is a systemic inflammatory disease, characterized by articular and extraarticular manifestations, including Interstitial Lung Disease (ILD). An early diagnosis of ILD can be essential in improving disease outcome. A clinical practice checklist has previously been proposed, highlighting red flags in signs and symptoms suggestive of RA-ILD. Our aim was to validate the "checklists of red flags signs or symptoms suggestive of RA-ILD" in our cohort of RA patients, by assessing the diagnostic utility of dyspnea, cough, and crackles, both individually and in combination. We performed a retrospective study including medical charts of consecutive RA patients. Our cohort included 107 patients with RA, from which 55 (51.4%) with a diagnosis of RA-ILD. Female patients were predominant in both RA-ILD and No-ILD groups (56.4% and 82.6% respectively), with a significantly higher proportion in the latter (p=0.0036). Dyspnea alone demonstrated a good diagnostic utility for RA-ILD with a sensitivity of 63.5% and specificity of 60%, PPV of 60% and an NPV of 63.5%, (p = 0.0203). Additionally, crackles exhibited the highest sensitivity among the individual symptoms (66.7%), a specificity of 57.4% and a significant association with RA-ILD (p = 0.0265). The presence of either dyspnea or crackles confirmed their strong association with RA-ILD (p=0.0066), with the highest level of accuracy (63.5%) and specificity (63.8%). Also, the combination of cough or dyspnea was significantly associated with RA-ILD (p = 0.0111). A strong correlation was observed between RA-ILD and the presence of both crackles and dyspnea (p = 0.0351). When the three symptoms were combined, the sensitivity was 64.3%, the specificity was 53.2%, the PPV was 32.7%, and the NPV was 81%, but did not reach statistical significance (p= 0.1284). Overall, crackles and dyspnea were the most significant markers of RA-ILD, both individually, and in combination. This study confirms that the red flags previously identified, especially in combination, show an important accuracy and reliability as clinical biomarkers in the early detection of RA-ILD.
Keywords: Interstitial Lung Disease, Rheumatoid arthritis, Dyspnea, Cough, Crackles
Received: 09 May 2025; Accepted: 25 Jun 2025.
Copyright: © 2025 Cela, Bonini, Cavalli, LUCIANO, Kroegler, Ora, Bergamini, Chiocchi, Rogliani, Chimenti and Conigliaro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Paola Conigliaro, Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome “Tor Vergata”, Rome, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.